Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-arm exploratory study of inhaled chloroquine phosphate for COVID-19 pneumonia
ChiCTR2000029975Phase 4Not yet recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of chloroquine in coronavirus disease 2019 (COVID-19) and pneumonia, sponsored by The First Hospital of Jilin University. Primary endpoints: viral negative-transforming time, 30-day cause-specific mortality and 2 more. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
chloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)pneumonia
Beyond the preview
Go deeper on ChiCTR2000029975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029975.